Literature DB >> 30801930

Pathophysiology, causes and genetics of paediatric and adult bronchiectasis.

Andrew Bush1,2,3, R Andres Floto4,5.   

Abstract

Bronchiectasis has historically been considered to be irreversible dilatation of the airways, but with modern imaging techniques it has been proposed that 'irreversible' be dropped from the definition. The upper limit of normal for the ratio of airway to arterial development increases with age, and a developmental perspective is essential. Bronchiectasis (and persistent bacterial bronchitis, PBB) is a descriptive term and not a diagnosis, and should be the start not the end of the patient's diagnostic journey. PBB, characterized by airway infection and neutrophilic inflammation but without significant airway dilatation may be a precursor of bronchiectasis, and there are many commonalities in the microbiology and the pathology, which are reviewed in this article. A high index of suspicion is essential, and a history of chronic wet or productive cough for more than 4-8 weeks should prompt investigation. There are numerous underlying causes of bronchiectasis, although in many cases no cause is found. Causes include post-infectious, especially after tuberculosis, adenoviral or pertussis infection; aspiration syndromes; defects in host defence, which may solely affect the airways (cystic fibrosis, not considered in this review, and primary ciliary dyskinesia); and primary ciliary dyskinesia or be systemic, such as common variable immunodeficiency; genetic syndromes; and anatomical defects such as intraluminal airway obstruction (e.g. foreign body), intramural obstruction (e.g. complete cartilage rings) and external airway compression (e.g. by tuberculous lymph nodes). Identification of the underlying cause is important, because some of these conditions have specific treatments and others genetic implications for the family.
© 2019 Asian Pacific Society of Respirology.

Entities:  

Keywords:  bronchiectasis; cough; immunodeficiency; radiology and other imaging; respiratory infections (non-tuberculous)

Mesh:

Year:  2019        PMID: 30801930     DOI: 10.1111/resp.13509

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Prevalence and risk factors for postinfectious cough in discharged patients with coronavirus disease 2019 (COVID-19).

Authors:  Yuehan Chen; Xu Zhang; Xiansheng Zeng; Tingting Xu; Wei Xiao; Xuejiao Yang; Wenzhi Zhan; Chen Zhan; Kefang Lai
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Network Pharmacology Analysis of the Therapeutic Mechanisms Underlying Beimu-Gualou Formula Activity against Bronchiectasis with In Silico Molecular Docking Validation.

Authors:  Xin Shen; Hong Li; Wen-Jun Zou; Jian-Ming Wu; Long Wang; Wei Wang; Hui Chen; Ling-Li Zhou; Yuan-Hui Hu; Xu-Hua Qin; Jing Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-05       Impact factor: 2.629

3.  Informatic analysis of the pulmonary microecology in non-cystic fibrosis bronchiectasis at three different stages.

Authors:  Yuchao Wang; Ying Chen; Chao Wu; Xiaohong Yang
Journal:  Open Life Sci       Date:  2022-02-28       Impact factor: 1.311

4.  A Paradigm Shift in the Diagnosis of Aspiration Pneumonia in Older Adults.

Authors:  Yuki Yoshimatsu; David G Smithard
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

Review 5.  New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease.

Authors:  Andrew J Wardlaw; Eva-Maria Rick; Leyla Pur Ozyigit; Alys Scadding; Erol A Gaillard; Catherine H Pashley
Journal:  J Asthma Allergy       Date:  2021-05-25

6.  Unusual Bronchial Foreign Bodies with Localized Bronchiectasis in Five Children.

Authors:  Xi-Ling Wu; Lei Wu; Zhi-Min Chen
Journal:  Case Rep Med       Date:  2019-12-28

Review 7.  Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review.

Authors:  Riccardo Inchingolo; Chiara Pierandrei; Giuliano Montemurro; Andrea Smargiassi; Franziska Michaela Lohmeyer; Angela Rizzi
Journal:  Antibiotics (Basel)       Date:  2021-03-20

8.  Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.

Authors:  Takashi Hirama; Fumiko Tomiyama; Hirotsugu Notsuda; Tatsuaki Watanabe; Yui Watanabe; Hisashi Oishi; Yoshinori Okada
Journal:  BMC Pulm Med       Date:  2021-08-13       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.